OT6.231 - Towards Mass-Sensitive Assay Formats for Medical Drugs Using MIP Nanobodies

Publications: Contribution to bookContribution to proceedingsPeer Reviewed

Abstract

Solid-phase synthesis of molecularly imprinted polymers yields nanoparticles that inherently may re-place antibodies in bioassays. Herein, we demonstrate the approach for mass-sensitive detection of two medical drugs, namely salbutamol and vancomycin. While both yield appreciable sensor respons-es on quartz crystal microbalances – for salbutamol including a competitive assay, the responses to vancomycin are limited due to template size (and, thus, fewer binding events). One way to overcome this is to link the MIP nanoparticles to heavier particles to increase the response per binding event.
Original languageEnglish
Title of host publicationProceedings, Chapter OT6 - Biochemical sensors, Microfluidics, Lab-on-a-Chip and Organ-On-Chip Systems
Pages 189 - 190
DOIs
Publication statusPublished - 1 Sept 2024

Austrian Fields of Science 2012

  • 104017 Physical chemistry
  • 202036 Sensor systems

Fingerprint

Dive into the research topics of 'OT6.231 - Towards Mass-Sensitive Assay Formats for Medical Drugs Using MIP Nanobodies'. Together they form a unique fingerprint.

Cite this